Increasing investment in gene therapy, rising adoption of biomarker profiling based diagnostic procedures, prevalence of genetic disorders & infectious diseases, and government initiatives towards development of new drugs are the major factors driving the global digital PCR market. Digital PCR is a quantitative measurement method for measuring the DNA or RNA present in a sample without dependency on calibration curve for quantification.
Digital PCR is widely used across clinical applications owing to the high accuracy, improved rare allele & CNV detection, and high detection sensitivity. The digital PCR plays a vital role in analysis & development of molecular biomarkers focused on development of precision or personalized medicine. Rising demand for biomarker based prognosis and diagnosis of chronic disorders such as cancer, and adoption of personalized medicine for improved treatment are actively driving the global digital PCR market. Consequently, the global digital PCR market is expected to witness prominent growth during the forecast period.
North America contributed the largest share to the global market in 2019 owing to increasing investment in development of novel genomic products, robust genetic research & development infrastructure, and early adoption of advanced diagnostic technologies. Additionally, increasing burden of cancer is fueling the demand for personalized medicine development, thereby accelerating the growth of North America digital PCR market.
Europe is anticipated to contribute a prominent share to the global digital PCR market during the forecast period owing to increasing investment in development of novel diagnostic equipment and therapeutics. Asia Pacific is anticipated to exhibit prominent growth in coming years backed by increasing investment in strengthening the biotechnology and pharmaceuticals industry.
Among the surgical procedures performed globally, the United States accounts for a major share due to the prevalence of chronic disorders, and expanding population. Increasing incidences of cancer, prevalence of infectious diseases, and adoption of ambulatory digital PCRs are the key factors contributing towards the demand for digital PCRs in North America. Asia Pacific is anticipated to offer lucrative opportunities to the manufacturers of digital PCRs in coming years owing to the expanding population and rising investment in strengthening the healthcare infrastructure. The growth of medical tourism and prevalence of chronic diseases are anticipated to be the key attributes towards the growth of Asia Pacific digital PCR market during the forecast period.
The report titled “Digital PCR Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032” wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global digital PCR market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Thermo Fisher Scientific reported revenues of USD 25.5 billion in 2019 and the product segment analysis of the company indicates that Life Sciences Solutions business segment of the company dominated revenue in 2019.
The global digital PCR market is segmented based on component, technology, application, end user, and geography. Based on component, the global digital PCR market is segmented into digital PCR equipment, consumables & reagents, and services. Based on technology, the global digital PCR market is segmented into droplet digital PCR (ddPCR), and BEAMing digital PCR. Based on applications, the global digital PCR market is segmented into clinical diagnostics, research, and forensics. Based on end user, the global digital PCR market is segmented into diagnostic laboratories, pharmaceuticals & biotechnology companies, and university & research centers. Based on geography, the global digital PCR market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on digital PCR. Further, market share of prominent companies in the global digital PCR market would also be estimated. For instance, Thermo Fisher Scientific operates through four business segments namely Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The digital PCRs are delivered under Life Sciences Solutions business segment of the company with revenue contribution of US$ 6.38 billion in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the digital PCR companies. The global digital PCR market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the digital PCR business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global digital PCR market.
Major players active in the global digital PCR market include Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Expedeon AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen N.V. (Formulatrix, Inc.), Stilla Technologies, Sysmex Corporation (Sysmex Inostics GmbH), and Thermo Fisher Scientific.